Show simple item record

dc.contributor.authorKumar, Mrityunjay
dc.contributor.authorBharti Nalin
dc.date.accessioned2022-06-15T09:46:56Z
dc.date.available2022-06-15T09:46:56Z
dc.date.issued2019-12
dc.identifier.citation306 - 324 pp
dc.identifier.issn0971-586X
dc.identifier.urihttp://hdl.handle.net/10973/54963
dc.publisherGokhale Institute of Politics and Economics (GIPE), Pune (India)
dc.relation.ispartofseriesVol. LXI; Issue 4
dc.titleProvisions of Generic Drugs under Section 3(d) of Indian IP Act: What does Data from the Backward States Reveal?
dc.typeArticle
dc.identifier.accnoav-2019-12-02


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record